Thursday, December 10, 2020

Alembic Pharmaceuticals receives USFDA final approval for Asenapine Sublingual tablets

Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.

from India Infoline News Service https://ift.tt/2JRD0Eg
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)